These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6174553)

  • 1. The psychopharmacological treatment of obsessive-compulsive disorder: a review.
    Insel TR; Murphy DL
    J Clin Psychopharmacol; 1981 Sep; 1(5):304-11. PubMed ID: 6174553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clomipramine treatment of obsessive-compulsive disorder. I. A controlled clinical trial.
    Thorén P; Asberg M; Cronholm B; Jörnestedt L; Träskman L
    Arch Gen Psychiatry; 1980 Nov; 37(11):1281-5. PubMed ID: 7436690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of clomipramine and nortriptyline in the treatment of obsessive-compulsive disorder: a double-blind, placebo-controlled trial.
    Noorbala AA; Hosseini SH; Mohammadi MR; Akhondzadeh S
    J Clin Pharm Ther; 1998 Apr; 23(2):155-9. PubMed ID: 9786103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Return of symptoms after discontinuation of clomipramine in patients with obsessive-compulsive disorder.
    Pato MT; Zohar-Kadouch R; Zohar J; Murphy DL
    Am J Psychiatry; 1988 Dec; 145(12):1521-5. PubMed ID: 3057923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multicentre, double-blind, comparison of fluvoxamine and clomipramine in the treatment of obsessive-compulsive disorder.
    Mundo E; Maina G; Uslenghi C
    Int Clin Psychopharmacol; 2000 Mar; 15(2):69-76. PubMed ID: 10759337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of obsessive-compulsive disorder with clomipramine and desipramine in children and adolescents. A double-blind crossover comparison.
    Leonard HL; Swedo SE; Rapoport JL; Koby EV; Lenane MC; Cheslow DL; Hamburger SD
    Arch Gen Psychiatry; 1989 Dec; 46(12):1088-92. PubMed ID: 2686576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of drug treatment in obsessive-compulsive disorder. A meta-analytic review.
    Piccinelli M; Pini S; Bellantuono C; Wilkinson G
    Br J Psychiatry; 1995 Apr; 166(4):424-43. PubMed ID: 7795913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clomipramine, clonazepam, and clonidine treatment of obsessive-compulsive disorder.
    Hewlett WA; Vinogradov S; Agras WS
    J Clin Psychopharmacol; 1992 Dec; 12(6):420-30. PubMed ID: 1474179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clomipramine and obsessive compulsive disorder: a placebo-controlled double-blind study of 32 patients.
    Greist JH; Jefferson JW; Rosenfeld R; Gutzmann LD; March JS; Barklage NE
    J Clin Psychiatry; 1990 Jul; 51(7):292-7. PubMed ID: 2195006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clomipramine versus fluoxetine in obsessive-compulsive disorder: a retrospective comparison of side effects and efficacy.
    Jenike MA; Baer L; Greist JH
    J Clin Psychopharmacol; 1990 Apr; 10(2):122-4. PubMed ID: 2140372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double-blind comparative study of clomipramine and amitriptyline in obsessive neurosis.
    Ananth J; Pecknold JC; van den Steen N; Engelsmann F
    Prog Neuropsychopharmacol; 1981; 5(3):257-62. PubMed ID: 7022517
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacotherapy of obsessive-compulsive disorder.
    Jermain DM; Crismon ML
    Pharmacotherapy; 1990; 10(3):175-98. PubMed ID: 2196535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obsessive-compulsive disorder: a double-blind, placebo-controlled trial of clomipramine in 27 patients.
    Jenike MA; Baer L; Summergrad P; Weilburg JB; Holland A; Seymour R
    Am J Psychiatry; 1989 Oct; 146(10):1328-30. PubMed ID: 2675643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of comorbid body dysmorphic disorder on the response to sequential pharmacological trials for obsessive-compulsive disorder.
    Diniz JB; Costa DL; Cassab RC; Pereira CA; Miguel EC; Shavitt RG
    J Psychopharmacol; 2014 Jun; 28(6):603-11. PubMed ID: 24288238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A double-blind study of adjuvant buspirone hydrochloride in clomipramine-treated patients with obsessive-compulsive disorder.
    Pigott TA; L'Heureux F; Hill JL; Bihari K; Bernstein SE; Murphy DL
    J Clin Psychopharmacol; 1992 Feb; 12(1):11-8. PubMed ID: 1552034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug treatment of obsessive-compulsive disorder: a review of findings in the light of diagnostic and metric limitations.
    Towbin KE; Leckman JF; Cohen DJ
    Psychiatr Dev; 1987; 5(1):25-50. PubMed ID: 2885832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clomipramine and imipramine in obsessive-compulsive disorder.
    Volavka J; Neziroglu F; Yaryura-Tobias JA
    Psychiatry Res; 1985 Jan; 14(1):85-93. PubMed ID: 3887445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluvoxamine versus clomipramine in the treatment of obsessive compulsive disorder: a multicenter, randomized, double-blind, parallel group comparison.
    Freeman CP; Trimble MR; Deakin JF; Stokes TM; Ashford JJ
    J Clin Psychiatry; 1994 Jul; 55(7):301-5. PubMed ID: 8071291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clomipramine treatment of childhood obsessive-compulsive disorder. A double-blind controlled study.
    Flament MF; Rapoport JL; Berg CJ; Sceery W; Kilts C; Mellström B; Linnoila M
    Arch Gen Psychiatry; 1985 Oct; 42(10):977-83. PubMed ID: 3899048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Controlled comparisons of clomipramine and fluoxetine in the treatment of obsessive-compulsive disorder. Behavioral and biological results.
    Pigott TA; Pato MT; Bernstein SE; Grover GN; Hill JL; Tolliver TJ; Murphy DL
    Arch Gen Psychiatry; 1990 Oct; 47(10):926-32. PubMed ID: 2222131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.